Key In-Vivo Imaging Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
The international in-vivo imaging market is readily characterized by a combination of advanced small-scale organizations and entrenched multinational conglomerates. Besides, notable strategies include a robust focus on research and developmental activities to pioneer hybrid multimodal systems and AI-powered analytics. Moreover, key players are increasingly integrating tactical acquisitions and partnerships to extend their geographic footprint and technological portfolios, particularly in highly developed nations. Meanwhile, an effective transition towards service-specific business models, such as long-lasting maintenance contracts, along with analytics-as-a-service, are also positively impacting the market’s growth across different nations.
Here is a list of key players operating in the global market:
|
Company Name (Country of Origin) |
Industry Focus & Notable Products |
2024 Market Share |
|
Siemens Healthineers (Germany) |
Full-portfolio diagnostic imaging: MRI, CT, PET, SPECT, angiography systems. Pioneer in PET/MRI and AI-based software |
20.9% |
|
GE HealthCare (U.S.) |
Broad portfolio in MRI, CT, PET, and ultrasound. Focus on digital solutions and precision care platforms |
19.3% |
|
PerkinElmer, Inc. (U.S.) |
Leading in preclinical imaging: IVIS spectrum, quantum GX micro-CT, high-content screening systems |
12.7% |
|
Bruker Corporation (U.S.) |
Preclinical MRI (PharmaScan), PET/SPECT/CT (Albira), and multimodal imaging systems |
9.6% |
|
Medtronic plc (Ireland) |
Focus on surgical and interventional imaging navigation systems and technologies |
7.5% |
|
Koninklijke Philips N.V. (Netherlands) |
Integrated diagnostic imaging (MRI, CT, PET, ultrasound) and connected informatics solutions |
xx% |
|
Miltenyi Biotec (Germany) |
Preclinical imaging platforms like the MILabs PET/SPECT/CT/OI systems for immunology research |
xx% |
|
Agilent Technologies, Inc. (U.S.) |
Provides in vivo imaging systems for preclinical research, including ultrasound and photoacoustic |
xx% |
|
Thermo Fisher Scientific Inc. (U.S.) |
Preclinical imaging solutions including micro-CT and optical imaging systems |
xx% |
|
Mindray Medical International Ltd. (China) |
Expanding portfolio in diagnostic ultrasound and emerging into other modalities |
xx% |
|
Esaote S.p.A. (Italy) |
Specialist in dedicated MRI and ultrasound systems, particularly musculoskeletal and point-of-care |
xx% |
|
Cardinal Health, Inc. (U.S.) |
Major player in radiopharmaceuticals and nuclear imaging agent supply chain |
xx% |
|
Curium Pharma (U.S./France) |
Global leader in nuclear medicine, supplying SPECT and PET radiopharmaceuticals |
xx% |
|
Lantheus Holdings, Inc. (U.S.) |
Develops and commercializes innovative diagnostic imaging agents like PYLARIFY (PET) |
xx% |
|
Trivitron Healthcare (India) |
Manufacturer of medical imaging equipment including CT, MRI, and PET-CT systems |
xx% |
|
Magnetic Insight, Inc. (U.S.) |
Focused on Magnetic Particle Imaging (MPI) technology and solutions |
xx% |
|
Advantage Medical Pty Ltd. (Australia) |
Provides medical imaging solutions and equipment distribution in the Australasia region |
xx% |
|
Samsung Medison (South Korea) |
Subsidiary of Samsung Electronics, focused on diagnostic ultrasound systems |
xx% |
|
United Imaging Healthcare (China) |
Developing full portfolio of advanced medical imaging systems including MRI, CT, and PET/CT |
xx% |
|
BCF Technology Ltd. (UK) |
Specializes in veterinary imaging systems including ultrasound and digital X-ray |
xx% |
Below are the areas covered for each company in the in-vivo imaging market:
